ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

NCI’s New Policy On Costly Research

December 10, 1993

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

Leukemia Society Program In Transitional Research.

January 14, 2000

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007